These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 4580130)

  • 1. [Electron microscopical studies on the host versus parasite reaction in experimental candida infections of the mouse: solitary candida cells in kidney tisue].
    Müller J; Douchet C; Sakuma S
    Dermatol Monatsschr; 1973 Apr; 159(4):327-30. PubMed ID: 4580130
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in host responses to experimental Candida albicans infections by bacterial endotoxin.
    Wright LJ; Kimball HR; Wolff SM
    J Immunol; 1969 Dec; 103(6):1276-82. PubMed ID: 4902896
    [No Abstract]   [Full Text] [Related]  

  • 6. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
    Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
    J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection.
    Zafirova Y; Yordanov M; Kalfin R
    Int Immunol; 2004 Aug; 16(8):1125-31. PubMed ID: 15237107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice.
    Tuite A; Elias M; Picard S; Mullick A; Gros P
    Genes Immun; 2005 Dec; 6(8):672-82. PubMed ID: 16079897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
    Huang W; Na L; Fidel PL; Schwarzenberger P
    J Infect Dis; 2004 Aug; 190(3):624-31. PubMed ID: 15243941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
    Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
    Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice.
    Cutler JE
    J Reticuloendothel Soc; 1976 Feb; 19(2):121-4. PubMed ID: 772202
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.
    Netea MG; van de Veerdonk F; Verschueren I; van der Meer JW; Kullberg BJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):118-23. PubMed ID: 18036178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of gastrointestinal colonization and systemic spread by Candida albicans and nonlethal yeast in the infant mouse.
    Pope LM; Cole GT
    Scan Electron Microsc; 1982; (Pt 4):1667-76. PubMed ID: 6764023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility.
    Fulurija A; Ashman RB; Papadimitriou JM
    J Med Vet Mycol; 1997; 35(3):197-203. PubMed ID: 9229336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of T-cells and intestinal bacteria on resistance of mice to candidosis.
    Lee KW; Balish E
    J Reticuloendothel Soc; 1982 Mar; 31(3):233-40. PubMed ID: 7042972
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of antineoplastic agents on experimental candidosis in mice.
    Ghannoum MA; Khattar M; Kayed F; Shridar P
    Mykosen; 1985 Aug; 28(8):369-74, 379-87. PubMed ID: 3930958
    [No Abstract]   [Full Text] [Related]  

  • 18. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
    Villamón E; Gozalbo D; Roig P; Murciano C; O'Connor JE; Fradelizi D; Gil ML
    Eur Cytokine Netw; 2004; 15(3):263-71. PubMed ID: 15542452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.